The Conversation (0)
Melodiol Global Health (ASX:ME1, FRA:1X8) is a significant player in the global cannabis market with a value proposition founded on its strategic operations in both Canada and Australia.
Melodiol oversees multiple global business units that provide everything from recreational and medical cannabis to hemp-based, athletic, beauty and personal care products. Through subsidiary Halucenex Life Sciences, the company has also dipped its toes into the medical psychedelics market.
Melodiol's two most significant subsidiaries, by far, are Mernova and Health House International. The former is a licensed Canadian producer of small-batch, high-quality craft cannabis with incredibly strong revenue growth. The former is a leading distributor of medical cannabis in Australia with additional non-cannabis operations in the United Kingdom.
Mernova is a 100-percent-owned subsidiary of Melodiol which produces high-quality craft cannabis for recreational use. Its products are among the most concentrated in the Canadian market, with THC content typically 25 percent or higher and are currently available in Saskatchewan, Ontario, Nova Scotia, New Brunswick, Manitoba, Yukon and Newfoundland. Mernova is notable as the first of Melodiol's divisions to generate positive cash flow from operations, achieving significant revenue growth in the first half of 2023. The company currently aims to bring its Mernova products to other markets within Canada and has recently launched a medicinal cannabis division.
Company Highlights
- A significant player in the global cannabis market, Melodiol Global Health is well-positioned to capitalise on a global trend toward recreational and medical cannabis legalization.
- Melodiol has built a diverse portfolio of plant-based brands situated in multiple high-growth market segments and geographies:
- Mernova, a licensed producer of craft cannabis products in Canada sold under the Ritual brand banner.
- Health House International is a leading Australian distributor of medicinal cannabis.
- Sierra Sage Herbs is an American developer of plant-based first aid, beauty and personal care brands Green Goo, Southern Butter and Good Goo.
- Creso ImpACTIVE, which produces high quality hemp-derived CBD products for athletes.
- Halucenex, a clinical-stage psychedelics research and development operation.
- Creso Pharma Switzerland, which carries out CBD-related research, development and commercialization initiatives.
- Melodiol has displayed incredibly strong financial performance throughout 2023, with significant revenue growth and notable improvements in core business unit EBITDA margins.
- The company intends to continue on its current path of generating value for shareholders through strong operational and financial performance.
This Melodiol Global Health profile is part of a paid investor education campaign.*
ME1:AU
